Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, 52-Week, Open-Label Extension Study (From Studies WEL-301, WEL-302, and WEL-303) to Evaluate the Long-Term Safety and Tolerability of WelChol® in Type 2 Diabetic Patients

NCT00151762 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00151762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00151762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, 52-Week, Open-Label Extension Study (From Studies WEL-301, WEL-302, and WEL-303) to Evaluate the Long-Term Safety and Tolerability of WelChol® in Type 2 Diabetic Patients
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
July 31, 2007
Enrollment
780
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes